Showing results (91-100 of 538) with videos related to
Sort By:
Pageof 54
Cancer|May 27, 2010
Differential regulation of the aggressive phenotype of inflammatory breast cancer cells by prostanoid receptors EP3 and EP4Fredika M Robertson, Ann-Marie Simeone, Anthony Lucci, et al.The Oncologist|November 7, 2023
Circulating Tumor Cells Prediction in Hormone Receptor Positive HER2-Negative Advanced Breast Cancer: A Retrospective Analysis of the MONARCH 2 TrialLorenzo Gerratana, Masha Kocherginsky, Andrew A Davis, et al.Cancer Treatment Reviews|July 12, 2023
The immunogram of inflammatory breast cancerCarmine Valenza, Dario Trapani, Nicola Fusco, et al.Biomedicines|April 3, 2021
The Role of Exosomes in Breast Cancer DiagnosisClaudia Piombino, Ilenia Mastrolia, Claudia Omarini, et al.International Journal of Cancer|March 5, 2015
Twenty-years experience with de novo metastatic breast cancerLaura Cortesi, Angela Toss, Claudia Cirilli, et al.Translational Oncology|October 27, 2015
A Preclinical Model of Inflammatory Breast Cancer to Study the Involvement of CXCR4 and ACKR3 in the Metastatic ProcessRoberto Wurth, Kevin Tarn, Danielle Jernigan, et al.International Review of Cell and Molecular Biology|September 22, 2023
Latest advances in clinical studies of circulating tumor cells in early and metastatic breast cancerLaura S Munoz-Arcos, Eleonora Nicolò, Mara S Serafini, et al.Radiology|March 29, 2008
Bone metastases in patients with metastatic breast cancer: morphologic and metabolic monitoring of response to systemic therapy with integrated PET/CTUkihide Tateishi, Cristina Gamez, Shaheenah Dawood, et al.The Prostate|January 16, 2008
Antisense MDM2 enhances the response of androgen insensitive human prostate cancer cells to androgen deprivation in vitro and in vivoZhaomei Mu, Paul Hachem, Harvey Hensley, et al.Biomedical Microdevices|July 30, 2008
Nanotechnology for breast cancer therapyTakemi Tanaka, Paolo Decuzzi, Massimo Cristofanilli, et al.Pageof 54